10-K 2026-09-10 ↗ compared with the previous 10-K 10-K 2025-08-29 ↗
Technical events and factor profile →
Palo Alto Networks adds risks from regulatory requirements in foreign jurisdictions and AI system vulnerabilities. Among the new risks: regulatory compliance expands in China and other countries, cloud provider capacity limitations impede customer onboarding and usage and customer configuration errors lead to security incidents and data breaches.
| After the 10-K | 1 session | 5 sessions | 20 sessions |
|---|---|---|---|
| PANW | +1.0% | +12.1% | +21.0% |
| Nasdaq-100 (QQQ) | -1.1% | -1.6% | +5.9% |
| Difference | +2.1% | +13.7% | +15.1% |
From the close before the filing. Historical data, not a prediction.
Our products and subscriptions are subject to regulatory requirements in a number of foreign jurisdictions, and the scope and complexity of these requirements continue to expand. For example, in China, our products may be required to comply with cybersecurity and data security laws, including the Cybersecurity Law, the Data Security Law, and related regulations, and may be subject to network security review, critical information infrastructure protection requirements, and mandatory product certifications. Other jurisdictions impose similar requirements, including local testing and certification requirements, in-country data storage or processing mandates, source code review or escrow obligations, and restrictions on the use of foreign-developed encryption or security technologies. Compliance with these requirements is costly and time-consuming, and the regulatory landscape in many jurisdictions is evolving and subject to change with limited or no notice. If we are unable to obtain or maintain required certifications, approvals, or authorizations in a timely manner, or if new or revised requirements render our products or subscriptions non-compliant, we may be unable to sell, deploy, or support our products in affected markets, which could result in lost revenue opportunities, reputational harm, and a material adverse effect on our business, financial condition, and operating results.
| Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.0B | $2.6B | $2.5B | $2.5B |
| YoY growth | +34.5% | +31.1% | +14.9% | +15.7% | +15.9% |
| Gross margin | 67.6% | 67.6% | 73.6% | 74.2% | 73.2% |
| Operating margin | 5.0% | -6.1% | 15.3% | 12.5% | 19.6% |
| Net income | -$282M | -$177M | $432M | $334M | $254M |
| Diluted EPS | -0.46 | -0.22 | 0.61 | 0.47 | 0.36 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
Similar than in the previous 10-K (2025-08-29: +11, +2 points)
10-K of 2026-09-10 · 20.9% positive sentences, 9.8% negative · 287 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Duquesne Family Office · Stanley Druckenmiller
held since Q2 2026 |
0.9% | $39.8M | new |
| Bridgewater Associates · Ray Dalio | — | sold | |
| ARK Investment Management · Cathie Wood | — | sold |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for PANW →
| 2026-10-09 | Bawa Aparna · Director | Sell | $70K | SEC ↗ |
| 2026-10-09 | Bawa Aparna · Director | Sell | $33K | SEC ↗ |
| 2026-10-01 | Paul Josh D. · Officer | Sell (10b5-1 plan) | $158K | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $3.7M | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $2.5M | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $2.1M | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $866K | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $842K | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $355K | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $350K | SEC ↗ |
| 2026-09-24 | Bawa Aparna · Director | Sell | $102K | SEC ↗ |
| 2026-09-24 | Golechha Dipak · CFO | Sell (10b5-1 plan) | $40K | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $1.8M | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $1.6M | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $1.3M | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $570K | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $488K | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $381K | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $340K | SEC ↗ |
| 2026-09-17 | GOETZ JAMES J · Director | Sell | $335K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.